Summary
- The paper proposes TimeWarn, an interpretable two-level attention model that explicitly incorporates irregular sampling intervals via a learned time-decay applied to both visit-level and variable-level attention. 
- On MIMIC-IV and eICU, TimeWarn outperforms strong baselines (including GRU-D and RETAIN) for predicting sepsis onset 6 hours in advance, with consistent gains across five seeds. 
- The model remains interpretable, highlighting clinically plausible variables (e.g., lactate, respiratory rate).

Strengths
- Addresses a clinically important problem (early sepsis warning) with clear operational framing (6-hour lead time).
- Methodologically sound extension of interpretable attention (RETAIN) to irregular time intervals via a simple, learnable decay that acts directly on attention, not just on the hidden state or inputs.
- Thorough evaluation across two large public ICU datasets, with five random seeds and both AUROC and AUPRC reported.
- Ablation demonstrating the necessity of time decay (and partial contribution when applied only to variable-level attention).
- Interpretability analysis aligns with clinical expectations (e.g., lactate, RR, MAP), improving trustworthiness.

Weaknesses and suggestions for improvement
- Statistical significance: Gains are modest but consistent. Please add significance testing (e.g., stratified bootstrap CIs or DeLong tests) to quantify whether improvements over GRU-D/RETAIN are statistically significant on test sets.
- Baseline tuning fairness: You tune TimeWarn via grid search but use original hyperparameters for baselines. Stronger evidence would come from (i) tuning key hyperparameters for GRU-D and RETAIN on your validation splits, and (ii) including at least one competitive transformer-based irregular-time model (e.g., time-aware/self-attentive models with relative/continuous-time embeddings), or ODE-RNN/Latent-ODE, if computationally feasible.
- Decay formulation and constraints: The decay γ = exp(−max(0, w·Δ + b)) is intuitive, but if w is unconstrained it could learn counterintuitive behavior (e.g., w < 0 makes γ increase with Δ). Consider constraining w ≥ 0 (e.g., parameterize w via softplus) and reporting learned distributions of w and b. Also compare against simpler baselines such as adding Δ as explicit features to the attention networks or using fixed half-life decays.
- Robustness and calibration: Add calibration metrics (Brier score, reliability diagrams) and threshold-based utility (e.g., PPV at 80% sensitivity, decision-curve analysis) to contextualize clinical deployment. Report subgroup performance (age, sex, race, hospital) to assess fairness. 
- Labeling and leakage: Since Sepsis-3 depends on timing of cultures/antibiotics, explicitly clarify that order-entry variables were excluded and that windows prior to onset do not include label-defining interventions. A timeline figure would help.
- Generalization: eICU spans many hospitals; consider hospital-wise splits or leave-one-hospital-out to test cross-site generalization. External validation outside the U.S. (if accessible) would strengthen claims.
- Practicality and compute: Report training/inference time and memory vs. GRU-D/RETAIN, and discuss alert rates at typical operating points to estimate clinical burden.
- Clarity gaps: 
  - Clarify how hourly window embeddings are built (imputation strategy, handling multiple measurements per hour, normalization, categorical handling, and missingness encoding).
  - Specify whether decimals are forward-filled and how carry-forward interacts with decay and masks.
  - Provide more detail on the grid search space and early-stopping protocol for all models and seeds.
  - State whether code and preprocessing pipelines will be released for reproducibility.

Questions for the authors
- Did you constrain w to be nonnegative or otherwise enforce monotonic decay with Δ? If not, what was observed empirically (e.g., histogram of learned w)?
- How sensitive are results to the choice of hourly binning (e.g., 30-min or 2-hour windows)?
- What proportion of predictions at 6 hours lead time are “early positives” that would have been missed by GRU-D at comparable sensitivity?
- Can you provide operating-point metrics (sensitivity-specificity pairs) corresponding to clinically meaningful thresholds?

Scores (0–100)
- Soundness: 82  
  Rationale: Solid architecture, coherent use of time decay with attention, appropriate datasets and metrics, and ablation. Needs significance testing, stronger baseline tuning, and more detail on decay constraints and preprocessing to be fully airtight.
- Novelty: 70  
  Rationale: Incremental but meaningful methodological contribution—time-aware scaling of both attention levels in an interpretable framework. Related to GRU-D’s decay idea, but applied to attention with a simple, learnable form.
- Significance: 80  
  Rationale: Addresses high-impact task; consistent gains on two large datasets; interpretable outputs. Gains are modest but relevant; stronger baselines and deployment-oriented analysis would further raise impact.
- Clarity: 88  
  Rationale: Generally well-written and easy to follow; includes key architectural and training details. Some missing specifics on preprocessing, decay constraints, and baseline tuning.

Final average score
- (82 + 70 + 80 + 88) / 4 = 80.0

Final recommendation
- Accept